Abstracts

Abstract Submission is Now Open

Submission Deadline: April 23, 2027

Acceptance Notification Date: April 30, 2027

Fee: No fee for non-industry-sponsored abstracts

$495 per abstract for industry-sponsored abstracts.

At least one (1) author (or representative) must be registered for the in-person meeting to have their abstracts considered for poster display

Submit Application

All accepted abstracts will be displayed at the 5th Annual Pigmentary Disorders Exchange Symposium.

Encore posters are welcome!

Topic

We invite all registered meeting attendees to submit abstracts for posters of their latest research on the following topics:

Medical and/or procedural therapies for pigmentary disorders
Studies addressing pathogenesis and epidemiology of pigmentary disorders

See Guidelines

Submission Criteria

At least one (1) author must be registered for the in-person meeting to have their abstracts considered for poster display.

Get Read By QxMD

Approved abstracts will be submitted and indexed through our partner brand Read by QxMD.

Download the App

The platform drives awareness, dissemination and engagement with this content via the Read by QxMD platform, as an educational tactic to drive CQI. ‘Read’ works on iPhone, iPad, Android smartphones & tablets and any web-enabled device (including desktops), and uses channels such as mobile, email and push notification to connect with our global community of healthcare providers and researchers.

Abstract Formatting and Content Guidelines

Language: English 

Authors: Full Last Name, First Name, Affiliations, Degrees, and contact information

BOLD the name of the Presenting Author and include the Presenting Author’s contact information

Submissions must be in Word

Maximum of 3000 characters, including spaces (not including the title, authors, or affiliations)

Maximum of 2 relevant tables or figures submitted as attachments (not embedded in the file): must be 600 dpi .jpg 

Provide titles for each table and/or figure

The author’s disclosures must be included to be accepted

Reference citations must be included as superscripted numbers in order of appearance, corresponding to a numbered reference list at the end of the abstract

Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email) 

Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, Conclusions, References (if appropriate), and Disclosures

Abstracts containing non-generic drug names, personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials will not be accepted

Note: Abstracts will not be accepted if the presenting author’s name is not bolded, presenting author’s email is not included and all faculty disclosures are not listed.

Optional publication of accepted posters in the Journal of Drugs in Dermatology (JDD).

If you have any questions, please contact abstracts@medscapelive.com.

Submit Application